Breakthroughs in Stem Cell Therapy

This chapter highlights the significant progress in biotechnology, focusing on an FDA-approved adult stem cell therapy for pediatric graft versus host disease. It discusses the therapy's development journey, market potential, and the innovative anti-inflammatory responses it elicits compared to traditional therapies. Additionally, the chapter addresses the financial, ethical, and regulatory challenges faced in the commercialization of this groundbreaking treatment, emphasizing its impact on future healthcare options.